Doximity (NYSE:DOCS) Upgraded to Strong-Buy at Wells Fargo & Company

Wells Fargo & Company upgraded shares of Doximity (NYSE:DOCS) from a hold rating to a strong-buy rating in a research note issued to investors on Tuesday morning,Zacks.com reports.

DOCS has been the topic of a number of other research reports. Truist Financial raised shares of Doximity from a “hold” rating to a “strong-buy” rating in a research note on Thursday, January 8th. Royal Bank Of Canada raised Doximity to a “moderate buy” rating in a research note on Thursday, January 8th. Barclays upgraded Doximity to a “strong-buy” rating in a report on Monday, December 8th. Weiss Ratings reissued a “hold (c+)” rating on shares of Doximity in a research report on Wednesday, December 24th. Finally, Wall Street Zen cut Doximity from a “buy” rating to a “hold” rating in a research note on Saturday, January 10th. Three analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, Doximity presently has an average rating of “Buy”.

Doximity Price Performance

DOCS opened at $41.11 on Tuesday. Doximity has a 12 month low of $39.95 and a 12 month high of $85.21. The firm has a market capitalization of $7.74 billion, a P/E ratio of 32.63, a PEG ratio of 1.91 and a beta of 1.39.

About Doximity

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.